Midgard Science
CO

Champions Oncology

Hackensack, NJ, United States championsoncology.com From their website, Nov 2026

Work here? Claim this listing

About

Champions Oncology is a preclinical oncology CRO providing patient-derived models, ex vivo and in vivo studies, and multi-omic data services for drug developers and researchers. It serves oncology programs across solid tumors, hematologic malignancies, CDX and PDX models, with operations in Hackensack, New Jersey; Rockville, Maryland; and Rehovot, Israel. The company also supports global studies through scientific consultation, model selection, and analytical readouts.

Services

  • Solid Tumor PDX Models

    Provides patient-derived xenograft models for solid tumor oncology research with clinical annotation and multi-omic characterization.

  • Blood Cancer Models

    Offers hematological tumor and leukemia xenograft models including AML, ALL, CLL, lymphoma, and multiple myeloma for preclinical testing.

  • Pretreated PDX Models

    Provides PDX models from pretreated patients to study resistance mechanisms, next-line therapies, and clinical translation.

  • CDX Models

    Offers cell line-derived xenograft models for proof-of-concept, target validation, resistance studies, and biomarker work.

  • PDX Model Bank

    Maintains a searchable bank of patient-derived tumor models for selecting models by tumor indication, modality, or molecular profile.

  • CDX Model Bank

    Provides a filtered bank of CDX models for selection by tumor indication, genetic profile, and gene expression.

  • TumorGraft3D Ex Vivo Platform

    Supports selected ex vivo studies using low-passage, PDX-derived 3D tumor models for cohort comparison and translational questions.

  • Hematological VitroScreen

    Runs ex vivo hematologic assays to test therapeutics in blood cancer models.

22 more services
  • Ex Vivo Solid Tumor Screening
  • In Vivo Preclinical Mouse Models
  • In Vivo Screening (Mouse Clinical Trials)
  • Matched Multi-Omic Dataset
  • Lumin Data Platform
  • Cell Surface Proteomics Dataset
  • KRAS-Mutant Atlas
  • Radiopharmaceutical Services
  • Analytical Assays
  • Co-Culture Assays
  • Ex Vivo Hematological Cancer Screen
  • Flow Cytometry
  • Histology / IHC
  • ELISA / Luminex
  • Next Generation Sequencing
  • 4D Proteomics
  • Western Blot
  • DNA Damage Assays
  • Colony Forming Unit (CFU) Assay
  • Imaging
  • Cell Viability & Proliferation
  • Quantitative PCR
Turnaround
  • Within 24 hours
  • Within one business day
What to send
  • Leukapheresis
  • Peripheral blood
  • Bone marrow aspirates
  • Biopsies of patients with advanced-stage disease

Capabilities

Assays and studies
  • In vivo
  • Rodent models
  • Flow cytometry
  • NGS
  • ADCs
  • ELISA
17 more
  • Antibodies
  • Histology
  • IHC
  • Luminex
  • Next generation sequencing
  • 4D proteomics
  • Western blot
  • DNA damage assays
  • Colony forming unit (CFU) assay
  • Imaging
  • Cell viability
  • Proliferation
  • Quantitative PCR
  • Co-culture assays
  • Proteomics
  • Phospho-proteomics
  • CFU assay
Scale and capacity
  • Over 1,500 patient-derived models
  • Over 1,400 patient-derived models
  • 700+ pretreated PDX models
  • 600+ cell-surface profiled models
  • 300+ TumorGraft3D models
  • 1,615 RNA-Seq models
7 more
  • 1,599 whole-exome models
  • 1,006 whole-cell protein models
  • 607 surface proteomics models
  • Over 1,500 highly characterized PDX models
  • 700+ pretreated models
  • Over 100 cell-line derived xenograft mouse models
  • 35,000 sq. ft. Rockville, MD research facility
Therapeutic areas
  • Oncology
  • Solid tumors
  • Hematologic malignancies
  • Bladder cancer
  • Prostate cancer
  • Kidney cancer
7 more
  • Melanoma
  • Skin cancer
  • Breast cancer
  • Colorectal cancer
  • Leukemia
  • Lymphoma
  • Multiple myeloma

Instruments and platforms

  • SPECT/CT
  • LC-MS
  • IVIS

Modalities and species

Modalities
  • Small molecule
  • Antibody
  • Bispecific
  • ADC
  • Cell therapy
Species and models
  • Human
  • Mouse
  • Patient-derived xenograft (PDX)
  • Cell line-derived xenograft (CDX)
  • Acute myeloid leukemia (AML)
  • Acute lymphoblastic leukemia (ALL)
14 more
  • Chronic lymphoblastic leukemia (CLL)
  • Diffuse large B-cell lymphoma (DLBCL)
  • Mantle cell lymphoma
  • Multiple myeloma
  • NSCLC
  • Colorectal cancer
  • Pancreatic cancer
  • Patient-derived xenografts (PDX)
  • Cell line-derived xenografts (CDX)
  • Syngeneic mouse models
  • Humanized mouse models
  • Solid tumor models
  • Blood cancer models
  • Hematological cancer models

Industries served

  • Biotech
  • Pharma
  • Oncology

Company

Type
CRO
Founded
2007
Quality
GCLP (clinical flow cytometry services)

Locations

Office
1330 Piccard Drive, Suite 025 & Suite 104 Rockville, MD 20850, USA
Sites
  • Rockville, USA
  • Rehovot, Israel
Serves
Global, U.S., globally, U.S.-based

Contacts

Similar labs